Covered recipient · General Payments record
TRISTAN IMHOF
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$9,154.38
- Reported across 407 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $752.97 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $230.14 | 11 |
| ABBVIE INC. | $170.04 | 6 |
| Acerta Pharma LLC | $86.94 | 1 |
| Lilly USA, LLC | $44.57 | 3 |
| Novo Nordisk AS | $33.20 | 2 |
| Exact Sciences Corporation | $33.12 | 2 |
| PFIZER INC. | $31.40 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $27.91 | 1 |
| SANOFI-AVENTIS U.S. LLC | $24.91 | 1 |
| Insulet Corporation | $23.59 | 1 |
| Medtronic, Inc. | $17.20 | 1 |
| GlaxoSmithKline, LLC. | $15.04 | 1 |
| VIVUS LLC | $14.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.90 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103966183 | CMS |
| ABBVIE INC. | $8.90 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103966185 | CMS |
| ABBVIE INC. | $11.21 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103966187 | CMS |
| ABBVIE INC. | $9.00 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103966189 | CMS |
| ABBVIE INC. | $7.03 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103966191 | CMS |
| ABBVIE INC. | $125.00 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103966193 | CMS |
| Amgen Inc. | $3.30 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585631 | CMS |
| Amgen Inc. | $15.06 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115750628 | CMS |
| Amgen Inc. | $18.25 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585633 | CMS |
| Amgen Inc. | $3.34 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585635 | CMS |
| Amgen Inc. | $8.40 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115750635 | CMS |
| Amgen Inc. | $3.47 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585637 | CMS |
| Amgen Inc. | $6.44 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115750644 | CMS |
| Amgen Inc. | $18.05 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585639 | CMS |
| Amgen Inc. | $121.13 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585643 | CMS |
| Amgen Inc. | $14.28 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585641 | CMS |
| Amgen Inc. | $18.42 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115750655 | CMS |
| AstraZeneca Pharmaceuticals LP | $86.94 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104467826 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $27.91 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086107088 | CMS |
| Exact Sciences Corporation | $16.52 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114713358 | CMS |
| Exact Sciences Corporation | $16.60 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114713364 | CMS |
| GlaxoSmithKline, LLC. | $15.04 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115788299 | CMS |
| Insulet Corporation | $23.59 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116813468 | CMS |
| Lilly USA, LLC | $13.96 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135461322 | CMS |
| Lilly USA, LLC | $16.37 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135502098 | CMS |
| Lilly USA, LLC | $14.24 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135451064 | CMS |
| Medtronic, Inc. | $17.20 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119438255 | CMS |
| Novo Nordisk Inc | $15.64 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096632480 | CMS |
| Novo Nordisk Inc | $17.56 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097821700 | CMS |
| PFIZER INC. | $14.15 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131808747 | CMS |
| PFIZER INC. | $17.25 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132082950 | CMS |
| SANOFI-AVENTIS U.S. LLC | $24.91 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139906868 | CMS |
| VIVUS LLC | $14.91 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129416190 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.